240 related articles for article (PubMed ID: 22708343)
21. Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil.
Höfling CC; Pavan EM; Giampaglia CM; Ferrazoli L; Aily DC; de Albuquerque DM; Ramos MC
Int J Tuberc Lung Dis; 2005 Jan; 9(1):87-93. PubMed ID: 15675556
[TBL] [Abstract][Full Text] [Related]
22. Performance of MTBDR plus for detecting high/low levels of Mycobacterium tuberculosis resistance to isoniazid.
Brossier F; Veziris N; Jarlier V; Sougakoff W
Int J Tuberc Lung Dis; 2009 Feb; 13(2):260-5. PubMed ID: 19146757
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens.
Hillemann D; Rüsch-Gerdes S; Richter E
J Clin Microbiol; 2007 Aug; 45(8):2635-40. PubMed ID: 17537937
[TBL] [Abstract][Full Text] [Related]
24. Direct detection in clinical samples of multiple gene mutations causing resistance of Mycobacterium tuberculosis to isoniazid and rifampicin using fluorogenic probes.
Espasa M; González-Martín J; Alcaide F; Aragón LM; Lonca J; Manterola JM; Salvadó M; Tudó G; Orús P; Coll P
J Antimicrob Chemother; 2005 Jun; 55(6):860-5. PubMed ID: 15879493
[TBL] [Abstract][Full Text] [Related]
25. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA.
Guo H; Seet Q; Denkin S; Parsons L; Zhang Y
J Med Microbiol; 2006 Nov; 55(Pt 11):1527-1531. PubMed ID: 17030912
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterization of isoniazid and rifampin resistance of Mycobacterium tuberculosis clinical isolates from Malatya, Turkey.
Aktas E; Durmaz R; Yang D; Yang Z
Microb Drug Resist; 2005; 11(2):94-9. PubMed ID: 15910221
[TBL] [Abstract][Full Text] [Related]
27. New insight into the molecular characterization of isoniazid and rifampicin resistant Mycobacterium tuberculosis strains from Saudi Arabia.
Varghese B; Hillemann A; Wijayanti DR; Shoukri M; Al-rabiah F; Al-Omari R; Al-Hajoj S
Infect Genet Evol; 2012 Apr; 12(3):549-56. PubMed ID: 22326932
[TBL] [Abstract][Full Text] [Related]
28. Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam.
Caws M; Duy PM; Tho DQ; Lan NT; Hoa DV; Farrar J
J Clin Microbiol; 2006 Jul; 44(7):2333-7. PubMed ID: 16825345
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis clinical isolates.
Wu X; Zhang J; Zhuang Y; Zhang X; Li G; He X
Chin Med J (Engl); 1999 Jun; 112(6):524-8. PubMed ID: 11601331
[TBL] [Abstract][Full Text] [Related]
30. Fast test for assessing the susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by real-time PCR.
Gonçalves MG; Fukasawa LO; Oliveira RS; Salgado MM; Harrison LH; Shutt KA; Sacchi CT
Mem Inst Oswaldo Cruz; 2012 Nov; 107(7):903-8. PubMed ID: 23147147
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanism of rifampicin and isoniazid resistance in Mycobacterium tuberculosis from Bangladesh.
Rahim Z; Nakajima C; Raqib R; Zaman K; Endtz HP; van der Zanden AG; Suzuki Y
Tuberculosis (Edinb); 2012 Nov; 92(6):529-34. PubMed ID: 22863574
[TBL] [Abstract][Full Text] [Related]
32. Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa.
Kiepiela P; Bishop KS; Smith AN; Roux L; York DF
Tuber Lung Dis; 2000; 80(1):47-56. PubMed ID: 10897383
[TBL] [Abstract][Full Text] [Related]
33. [Distribution of mutations in the rpoB, katG, inhA, ahpC gene of rifampicin and isoniazid resistant M. tuberculosis strains isolated in Kyrgyz Republic].
Isakova ZhT
Mol Gen Mikrobiol Virusol; 2008; (4):36-8. PubMed ID: 19172878
[TBL] [Abstract][Full Text] [Related]
34. Drug resistance-conferring mutations in Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia.
Tadesse M; Aragaw D; Dimah B; Efa F; Abdella K; Kebede W; Abdissa K; Abebe G
Int J Mycobacteriol; 2016 Jun; 5(2):185-91. PubMed ID: 27242230
[TBL] [Abstract][Full Text] [Related]
35. Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation.
Nikolayevsky V; Brown T; Balabanova Y; Ruddy M; Fedorin I; Drobniewski F
J Clin Microbiol; 2004 Oct; 42(10):4498-502. PubMed ID: 15472300
[TBL] [Abstract][Full Text] [Related]
36. Detection of Mycobacterium tuberculosis resistance mutations to rifampin and isoniazid by real-time PCR.
Hristea A; Otelea D; Paraschiv S; Macri A; Baicus C; Moldovan O; Tinischi M; Arama V; Streinu-Cercel A
Indian J Med Microbiol; 2010; 28(3):211-6. PubMed ID: 20644308
[TBL] [Abstract][Full Text] [Related]
37. [Characterization of the katG, inhA, ahpC, kasA, and oxyR gene mutations in isoniazid-resistant and susceptible strain of Mycobacterium tuberculosis by automated DNA sequencing].
Chen X; Ma Y; Jin Q; Jiang GL; Li CY; Wang Q
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Apr; 28(4):250-3. PubMed ID: 15854436
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Ontario, Canada.
Bolotin S; Alexander DC; Chedore P; Drews SJ; Jamieson F
J Antimicrob Chemother; 2009 Aug; 64(2):263-6. PubMed ID: 19520719
[TBL] [Abstract][Full Text] [Related]
39. Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Jagielski T; Bakuła Z; Roeske K; Kamiński M; Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J
J Antimicrob Chemother; 2014 Sep; 69(9):2369-75. PubMed ID: 24855126
[TBL] [Abstract][Full Text] [Related]
40. [Mechanisms of action of and resistance to rifampicin and isoniazid in Mycobacterium tuberculosis: new information on old friends].
De La Iglesia AI; Morbidoni HR
Rev Argent Microbiol; 2006; 38(2):97-109. PubMed ID: 17037259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
